Medical cannabis biopharma company MGC Pharmaceuticals (ASX:MXC) has launched its first Derma Plus product.
MGC’s Derma division officially launched the Herbal Repair Cream which is used to treat psoriasis.
The product is available through eCommerce platforms including the MGC Derma website, as well as existing commercial distribution channels.
The three products in the Derma Plus range were successfully tested in clinical trials during the second half of FY2017.
The other two products in the range, which are used for the relief of acne and dermatitis, will be launched during the first quarter of 2018.
Shares in MGC Pharmaceuticals (ASX:MXC) are trading 6.4 per cent lower to 9 cents.